Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric Mycoplasma pneumoniae pneumonia: a real-world evidence study

ObjectiveThis study aims to compare real-world clinical response, safety, and institutional medication efficiency of intravenous (IV) azithromycin (AZI) versus erythromycin lactobionate (ERY) in hospitalized children with Mycoplasma pneumoniae pneumonia (MPP).MethodsA retrospective cohort of 1,049 c...

Полное описание

Библиографические подробности

Главные авторы:	Jiayu Deng, Yifei Li, Changxin Liu, Xiaoyu Qu, Yanqing Song
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2026-02-01
Серии:	Frontiers in Cellular and Infection Microbiology
Предметы:	azithromycin erythromycin lactobionate intravenous macrolides medication efficiency Mycoplasma pneumoniae pneumonia propensity score matching
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fcimb.2026.1782840/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!